DABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells

dc.contributor.authorFernandes, Ana Rita
dc.contributor.authorDos Santos, Tiago
dc.contributor.authorGranja, Pedro L.
dc.contributor.authorSánchez-López, E. (Elena)
dc.contributor.authorSantini, Antonello
dc.contributor.authorGarcía López, María Luisa
dc.contributor.authorSilva, Amélia M.
dc.contributor.authorSouto, Eliana B.
dc.date.accessioned2021-11-25T13:57:33Z
dc.date.available2021-11-25T13:57:33Z
dc.date.issued2021-10-10
dc.date.updated2021-11-25T13:57:33Z
dc.description.abstractQuaternary derivatives of 1,4-diazabicyclo[2.2.2]octane (DABCO) and of quinuclidine surfactants were used to develop oil-in-water nanoemulsions with the purpose of selecting the best long-term stable nanoemulsion for the ocular administration of triamcinolone acetonide (TA). The combination of the best physicochemical properties (i.e., mean droplet size, polydispersity index, zeta potential, osmolality, viscoelastic properties, surface tension) was considered, together with the cell viability assays in ARPE-19 and HMC3 cell lines. Surfactants with cationic properties have been used to tailor the nanoemulsions' surface for site-specific delivery of drugs to the ocular structure for the delivery of TA. They are tailored for the eye because they have cationic properties that interact with the anionic surface of the eye. Keywords: cationic nanoemulsions, DABCO surfactants, quinuclidine surfactants, ocular administration, triamcinolone acetonide, age-related macular degeneration, HMC3 cell line, ARPE-19 cell line
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec714860
dc.identifier.issn1999-4923
dc.identifier.pmid34683945
dc.identifier.urihttps://hdl.handle.net/2445/181514
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics13101652
dc.relation.ispartofPharmaceutics, 2021, vol. 13, num. 1652
dc.relation.urihttps://doi.org/10.3390/pharmaceutics13101652
dc.rightscc-by (c) Fernandes, Ana Rita et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationEmulsions (Farmàcia)
dc.subject.classificationNanofluids
dc.subject.classificationFarmacologia ocular
dc.subject.classificationNanociència
dc.subject.otherEmulsions (Pharmacy)
dc.subject.otherNanofluids
dc.subject.otherOcular pharmacology
dc.subject.otherNanoscience
dc.titleDABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
714860.pdf
Mida:
2.03 MB
Format:
Adobe Portable Document Format